Establishments or authorised organisations shall draw up and keep up-to-date a full list of the agreements they have entered into with third parties whose involvement has an influence on the quality and safety of advanced therapy medicinal products prepared on an ad hoc basis. They shall make these agreements available to the Agence nationale de sécurité du médicament et des produits de santé and to the inspectors mentioned in article L. 5313-1.